CJC/IPA 10mg

Product specifications

• Product: CJC/IPA 10mg
• Composition per vial: CJC without DAC 5mg + ipamorelin 5mg
• Total peptide content: 10mg per vial
• Blend ratio: 1:1 by mass
• Brand: Kelden Peptide Sciences Canada

Research background

This blend brings together a GHRH analogue without the drug-affinity complex (DAC) and ipamorelin, a growth hormone secretagogue. Research interests include pituitary signaling and the response to compounds acting through different growth-hormone-release pathways. Studies of long-acting CJC-1295 with DAC should not be treated as evidence for the pharmacokinetics of this no-DAC product.

Raun and colleagues characterized ipamorelin in cell and animal experiments, reporting growth-hormone-releasing activity and selectivity under the tested conditions. These findings concern the individual compound and do not establish clinical benefits or validated performance of this specific 5mg/5mg blend.

Research reference: Raun et al., 1998 — Ipamorelin, the first selective growth hormone secretagogue.

Laboratory handling

Follow batch-specific documentation and your validated laboratory protocol for storage and sample preparation. Purity, identity and other quality attributes should be assessed against the corresponding batch certificate of analysis.

Intended use: Laboratory research only. Not for human or veterinary use.

For larger orders, visit our wholesale page to enquire about quantity pricing and availability. Include the product name and required quantity with your enquiry.

Request Wholesale Pricing